Mahesh V. Madhavan, MD, MS

565 posts

Mahesh V. Madhavan, MD, MS banner
Mahesh V. Madhavan, MD, MS

Mahesh V. Madhavan, MD, MS

@MVMadhavanMD

Structural Interventional Cardiologist and Clinical Investigator @columbiacardio | @nypcucvi | @nyphospital | @crfheart. Tweets are my own.

New York, NY Katılım Şubat 2013
713 Takip Edilen1K Takipçiler
Mahesh V. Madhavan, MD, MS retweetledi
Davide Capodanno
Davide Capodanno@DFCapodanno·
In the EXCEL trial, the lower rate of myocardial infarction after CABG was largely driven by fewer events related to graft failure and fewer infarctions arising from untreated vessels, compared with the higher burden of stent failure–related events and infarctions in non-stented vessels after PCI. In contrast, there was no evidence to support the traditional theory that CABG reduces MI by protecting against new events occurring proximal to the graft insertion site. ahajournals.org/doi/full/10.11…
Davide Capodanno tweet media
English
8
35
112
11.8K
Mahesh V. Madhavan, MD, MS retweetledi
Circulation
Circulation@CircAHA·
trial analysis: Spontaneous MI occurs more frequently after PCI vs CABG for left main disease (6.8% vs 3.4% at 5 years) and strongly predicts cardiovascular & all-cause mortality. Key consideration for Heart Team decision-making in LMCAD ahajrnls.org/3Oji6Px
Circulation tweet media
English
1
7
15
1.9K
Mahesh V. Madhavan, MD, MS retweetledi
Columbia Surgery
Columbia Surgery@ColumbiaSurgery·
🧵2/Scenes from today's opening sessions!
Columbia Surgery tweet mediaColumbia Surgery tweet mediaColumbia Surgery tweet media
English
1
1
3
254
Mahesh V. Madhavan, MD, MS retweetledi
Columbia Surgery
Columbia Surgery@ColumbiaSurgery·
🧵1/ It’s an interventional cardiology takeover this weekend at #TCT2025 in San Francisco! Day 1 kicks off with the Cardiovascular Nurse and Technologist Symposium — and we’re excited to highlight Columbia’s team leading conversations and innovation across sessions👇
English
1
2
5
621
Mahesh V. Madhavan, MD, MS retweetledi
Dr. Gilbert Tang
Dr. Gilbert Tang@GilbertTangMD·
Congrats @MMarinCuartas @SyedZaidMD et al for the CUTTING-EDGE failed M-TEER registry MV repair vs replacement JUST OUT @JACCJournals #JACCINT! Most MV gets replaced with worse outcomes. Will see how REPAIR-MR and PRIMARY trial play out down the road! jacc.org/doi/full/10.10…
Dr. Gilbert Tang tweet mediaDr. Gilbert Tang tweet mediaDr. Gilbert Tang tweet mediaDr. Gilbert Tang tweet media
Mateo Marín-Cuartas@MMarinCuartas

📣Surgical Mitral Valve Repair vs Replacement After Failed Mitral Transcatheter Edge-to-Edge Repair: The CUTTING-EDGE Registry @JACCJournals 🔗Full text: sciencedirect.com/science/articl…

English
0
7
25
3.8K
Mahesh V. Madhavan, MD, MS
Mahesh V. Madhavan, MD, MS@MVMadhavanMD·
Wonderful session with a lively discussion on available data and emerging treatment options for mitral and tricuspid disease! #AHA24
Mahesh V. Madhavan, MD, MS tweet media
Mahesh V. Madhavan, MD, MS@MVMadhavanMD

Excited for upcoming @TCTConference @AHAScience session on novel mitral + tricuspid therapies! Moderated by @hahn_rt + @gu_asc1 with all-star speakers/panelists. Will be great - don’t miss out!! @psorajja @anitaasgar @LindenfeldJoann @LindaGillamMD @NegarSalehiMD @crfheart #AHA24

English
1
1
7
858
Mahesh V. Madhavan, MD, MS retweetledi
Philippe Genereux
Philippe Genereux@PhilGenereuxMD·
Thanks Mahesh! Great discussion and great engagement with Panel and Audience! #AHA24 @AHAScience Thanks @djc795 @tavrkapadia @MartyBLeon #EARLY-TAVR @JACCJournals @NEJM
Mahesh V. Madhavan, MD, MS@MVMadhavanMD

Packed house for Preventive Management of Aortic Stenosis Session at #AHA24 @AHAScience. Great talk by @PhilGenereuxMD on #EARLYTAVR. How will recent studies on upstream management of AS affect your clinical practice? @djc795 @tavrkapadia @georgedangas @Drroxmehran @crfheart

English
0
1
10
964
Mahesh V. Madhavan, MD, MS
Mahesh V. Madhavan, MD, MS@MVMadhavanMD·
Do we think recent studies will impact guidelines? When is optimal time for intervention?
English
0
0
4
188
Philippe Pibarot
Philippe Pibarot@PPibarot·
Thanks to my lab dream team for this 60 yo birthday surprise party and this amazing gift fabricated by the engineers in my team. Woaw !
Philippe Pibarot tweet media
English
7
3
69
2.1K
Mahesh V. Madhavan, MD, MS retweetledi
Cardiovascular Research Foundation
Cardiovascular Research Foundation@crfheart·
🌟 Dr. Martin Leon introduces #NYValves2024 – the definitive meeting in valvular heart disease! 🌟 🗽 Join us in NYC for an exciting educational experience where the power of #HeartTeam collaboration takes center stage. 💪 From transcatheter valve therapy and imaging to surgical techniques and clinical cardiology, this conference covers it all! 🫀Register now! Prices increase on June 4. nyvalves2024.crfconferences.com/register #CardioTwitter #CardioX @anita_asgar @bapat_savrtavr @BurkhoffMd @djc795 @MCoylewright @samdawkins @npfam1 @igeorge1975 @jgranadacrf @AdamGreenbaumMD @hahn_rt @azeemlatib @MartyBLeon @TheDoctorMack @Drroxmehran @modine_thomas @Drdevignair @tnazifMD @Reismanmmd @drrahulpsharma @drnvanmieghem @vonBardelebenRS @DeeDeeWangMD @johngraydonwebb @PradeepYadavMD @mirvatalasnag @triciarawh
English
1
27
66
45.7K
Behnood Bikdeli
Behnood Bikdeli@bbikdeli·
When I was a child #DrBraunwald @TIMIStudyGroup was one of my heroes🦸‍♂️...Playing w my toy🚗🚘on tracks made of his 📚! Extreme joy to meet him first time 12Y ago…Now, so 🙏🙏 to learn from him RE fibrinolytic therapy, what he's contributed so much to! #thrombosis #CardioTwitter
Behnood Bikdeli tweet media
Behnood Bikdeli@bbikdeli

Historical perspectives RE #fibrinolytic therapy @SemThrombHemost . Don’t miss the Figure! 👏👏 @SinaRsh & an amazing team. A special paper for me, as I got to read & learn about work of giants, including my mentors @BrighamResearch @TIMIStudyGroup: 👇tinyurl.com/ytnxuyvr

English
1
4
39
3.1K

Keşfet

@GreggWStone @MyJSCAI @SCAI @ArnarGeirssonMD @ColumbiaSurgery @ColumbiaCVRI @TCTConference @colinbarkerMD